APNA CLINICAL PSYCHOPHARMACOLOGY INSTITUTE
VIRTUAL PROGRAM

Adapting & Innovating: Psychopharmacological Nursing Care in the Midst of Crisis

 

Women listening to a presentation at the Clinical Psychopharmacology Institute

Earn 20+ contact hours in pharmacology Thursday - Sunday.

Register Now

Thursday, June 10

 

3.0 Contact Hours

 

2:00pm - 3:00pm Eastern
1:00pm Central | 11:00am Pacific

CPI Kickoff: Attendee Networking Chat & Virtual Exhibit Hall Open


3:00pm - 4:30pm Eastern
2:00pm Central | 12:00pm Pacific

1.5 Contact Hours
 


KEYNOTE:  Mental Health Impacts of COVID-19
Joshua A. Gordon, MD, PhD

Dr. Gordon will review new scientific discoveries and how they impact your practice, with specific attention to emerging research around the current pandemic and mental health.


4:40pm - 6:10pm Eastern
3:40pm Central | 1:40pm Pacific

1.5 Contact Hours


When Substance Use Impacts the Professional: Recognition, Recovery, and Practice Challenges
Michelle Knapp, DNP, PMHNP-BC, FIAAN & Robert J. Abel DNP, PMHNP-BC

Discuss how individual institution and state regulatory policies surrounding nurses’ treatment for substance use disorders perpetuate stigma and how to shift nursing to a recovery-focused culture.

 
Friday, June 11
6.0 Contact Hours


9:00am - 10:00am Eastern
8:00am Central | 6:00am Pacific


Attendee Networking Chat & Virtual Exhibit Hall Open


10:00am - 11:30am Eastern
9:00am Central | 7:00am Pacific

1.5 Contact Hours


KEYNOTE: Alcohol Use Disorder: Hyperkatifeia, Deaths of Despair and COVID-19
George F. Koob, PhD

Delve into the science behind alcohol and stress, especially within the context of the COVID-19 pandemic, as well as current treatments for AUD, such as effective behavioral treatments and FDA approved medications for alcohol misuse.


11:40am - 1:10pm Eastern
10:40am Central | 8:40am Pacific

1.5 Contact Hours


Integrated Care of Elders to Manage Psychological Stress in the Midst of a Crisis
Kathleen D. Wright, PhD, RN, APRN-CNS, PMHCNS-BC

Explore chronic stress in aging, including discrimination stress and COVID-19 stress, the physiologic impact, and an integrated approach to stress-management in elders.


1:10pm - 2:10pm Eastern
12:10pm Central | 10:10am Pacific


Product Theater: Impact of Tardive Dyskinesia: Biopsychosocial Perspectives from Patients and Experts
Carmen Kosicek, APRN, MSN,PMHNP-BC; Amber Hoberg, APRN, MSN, PMHNP-BC

Sponsored by Teva Pharmaceuticals


2:10pm - 2:40pm Eastern
1:10pm Central | 11:10am Pacific


Break
Attendee Networking Chat & Virtual Exhibit Hall Open


2:40pm - 4:10pm Eastern
1:40pm Central | 11:40am Pacific

1.5 Contact Hours


Assessment and Treatment of Chronic Pediatric Irritability
Ellen Leibenluft, MD

Focus in on the assessment and treatment, both psychopharmacologic and psychotherapeutic, of chronic pediatric irritability, which is characterized by developmentally inappropriate temper outbursts and grouchy, angry mood between outbursts.


4:20pm - 5:50pm Eastern
3:20pm Central | 1:20pm Pacific

1.5 Contact Hours


Gut-Brain Axis and Neuroendocrinology: Translation to Addiction Medicine
Lorenzo Leggio, MD, PhD

Better understand systems related to the gut-brain axis and neuroendocrine pathways and develop treatments for alcohol and substance use disorder based on recent preclinical and clinical findings.

 
Saturday, June 12
6.0 Contact Hours


9:00am - 10:00am Eastern
8:00am Central | 6:00am Pacific


Attendee Networking Chat & Virtual Exhibit Hall Open


10:00am - 11:30am Eastern
9:00am Central | 7:00am Pacific

1.5 Contact Hours


Psychosis: Early Treatment, Outcomes, and Course
Nina R. Schooler, PhD

Explore the long-term course of treatment for schizophrenia, drawing on data from studies of the first episode of psychosis that include both psychological and pharmacological treatments, recent antipsychotic treatment advances and team-based communication with patients and families.


11:40am - 1:10pm Eastern
10:40am Central | 8:40am Pacific

1.5 Contact Hours


Demystifying Clozapine: Insights into its Unique Mechanism of Action and Practical Tips for Use
Robert O. Cotes, MD & Donna Rolin, PhD, APRN, PMHCNS-BC, PMHNP-BC

Through clinical case studies and discussion, gain an understanding of clozapine’s complex mechanism of action and best practices in prescribing, educating patients, and monitoring side effects for this uniquely efficacious antipsychotic medication.


2:10pm - 2:40pm Eastern
1:10pm Central | 11:10am Pacific


Break
Attendee Networking Chat & Virtual Exhibit Hall Open


2:40pm - 4:10pm Eastern
1:40pm Central | 11:40am Pacific

1.5 Contact Hours


Deprescribing Psychotropic Medications Using the 6-D Strategy
Erica D. Kierce, DNP, PMHNP

This presentation will provide the prescriber with a structured approach to the deprescribing process. Practical applications and case examples will be provided.


4:20pm - 5:50pm Eastern
3:20pm Central | 1:20pm Pacific

1.5 Contact Hours


Transforming the Mental Health Care System with Cultural Safety Care
Eugenia I. Flores Millender, PhD, RN, PMHNP-BC, CDE

Learn important considerations for providing culturally appropriate care and prescribing psychopharmacological medications for culturally diverse patients.

Sunday, June 13
6.0 Contact Hours

 

9:00am - 10:00am Eastern
8:00am Central | 6:00am Pacific

Attendee Networking Chat & Virtual Exhibit Hall Open


10:00am - 11:30am Eastern
9:00am Central | 7:00am Pacific

1.5 Contact Hours


Current Concepts in the Neurobiology and Psychopharmacology of ADHD Across the Lifecycle
Joseph Biederman, MD

Benefit from a comprehensive overview of the neurobiological basis of ADHD, patterns of comorbidity and dysfunctions associated with it, and an overview of the available safe and effective treatments to improve it.


11:40am - 1:10pm Eastern
10:40am Central | 8:40am Pacific

1.5 Contact Hours


Update on Research in PTSD
Thomas C. Neylan, MD

Hear the latest strategies for developing targeted psychopharmacological treatments for PTSD that are derived from clinical neuroscience.


1:10pm - 1:40pm Eastern
12:10pm Central | 10:10am Pacific


Break
Attendee Networking Chat & Virtual Exhibit Hall Open


1:40pm - 3:10pm Eastern
12:40pm Central | 10:40am Pacific

1.5 Contact Hours


Psychiatric Treament for Persons with HIV
Glenn J. Treisman, MD, PhD

Discover the latest best practices in psychopharmacological clinical care for persons infected with HIV as well as insight into the psychiatric aspects of HIV infections.


3:20pm - 4:50pm Eastern
2:20pm Central | 12:20pm Pacific

1.5 Contact Hours


Telepsychiatry: Opportunities and Challenges, Prescribing Across the Lifespan
Joy A. Lauerer, DNP, PMHCNS-BC RN & Mary D. Moller, DNP, ARNP, PMHCNS-BC, CPRP, FAAN

Understand population-specific prescribing guidelines for using telepsychiatry when working with adults or children.


 


Register Now

CPI provides up to 21 total contact hours.

 

Program is subject to change.  Please continue to check this page for updates.
The content of this Nursing Continuing Professional Development activity pertains to pharmacology. Because states' requirements may vary, contact your Board of Nursing for more information.

The American Psychiatric Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.